Notable Analyst Rating Changes 9/2: (TEVA) (PES) (AMFW) Upgraded; (STM) (NVO) (GCO) Downgraded
Tweet Send to a Friend
UPGRADES
Oppenheimer raises Teva Pharma (NYSE: TEVA) from Perform to Outperform with a price target of $66. Click Here ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer raises Teva Pharma (NYSE: TEVA) from Perform to Outperform with a price target of $66. Click Here ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
